News
(2)April 2026
Lunai Bioworks Inc. — PRE 14A Filing
# 🧾 What This Document Is This is a **PRELIMINARY PROXY STATEMENT (PRE 14A)**. Think of it as an advance notice and information packet sent to shareholders before a major vote. Lunai Bioworks is calling a special meeting because they need shareholders to approve a critical move to stay listed on th
March 2026
Lunai Bioworks Inc. — 8-K Filing
# 🔖 What This Document Is This is an **8-K filing** with an attached **Exchange Agreement** (Exhibit 10.1). An 8-K is a "current report" companies use to announce major events to shareholders. 👉 In simple terms: Lunai Bioworks is announcing a deal to **swap company debt for ownership shares**. A
Peers in Biotechnology
Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.